REVELATION BIOSCIENCES INC (REVB) Stock Earnings & Estimates
NASDAQ:REVB - US76135L6065 - Common Stock
2.73 USD
+0.03 (+1.11%)
2.7886 USD
+0.06 (+2.15%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 88.91% | N/A 117.19% | N/A 41.49% | |||||||
| EBITDA YoY % growth | N/A | -2.531M | -11.934M -371.58% | -10.839M 9.17% | -8.632M 20.37% | -7.947M 7.93% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.64K | -2.531M -69,421.98% | -11.951M -372.24% | -10.865M 9.09% | -8.657M 20.32% | -7.975M 7.87% | N/A -24.23% | N/A -10.16% | N/A -5.00% | N/A 243.44% | N/A 151.92% | N/A 151.36% | N/A 46.21% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -11,769.60 74.28% | 884.32 107.51% | -149.82 -116.94% | N/A 91.87% | N/A 39.25% | N/A 27.17% | N/A 128.41% | N/A 145.33% | N/A 145.38% | N/A 44.41% |
All data in USD
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -1.62 87.93% | -1.62 89.14% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -2.574M -43.29% | -2.642M -50.62% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -7.01 91.46% | -4.54 | -2.47 | -54.27% |
| Q1 2025 Q2Q % growth | -6.33 83.92% | -21.05 | 14.72 | 69.93% |
| Q4 2024 Q2Q % growth | -14.94 88.79% | -16.65 | 1.71 | 10.25% |
| Q3 2024 Q2Q % growth | -13.44 93.33% | -46.35 | 32.91 | 71.00% |
| Q2 2024 Q2Q % growth | -82.08 31.60% | -29.46 | -52.62 | -178.64% |
| Q1 2024 Q2Q % growth | -39.36 -102.94% | -87.88 | 48.52 | 55.21% |
| Q4 2023 Q2Q % growth | -133.28 84.31% | -224.73 | 91.45 | 40.69% |
| Q3 2023 Q2Q % growth | -201.60 80.00% | -146.88 | -54.72 | -37.25% |
| Q2 2023 Q2Q % growth | -120.00 94.05% | -195.84 | 75.84 | 38.73% |
| Q1 2023 Q2Q % growth | 1,339.20 116.96% | -318.24 | 1,657.44 | 520.81% |
| Q4 2022 Q2Q % growth | -849.60 | -856.80 | 7.20 | 0.84% |
| Q3 2022 Q2Q % growth | -1,008.00 | -1,542.24 | 534.24 | 34.64% |
| Q2 2022 Q2Q % growth | -2,016.00 | -2,399.04 | 383.04 | 15.97% |
| Q1 2022 Q2Q % growth | -7,896.00 | -2,399.04 | -5,496.96 | -229.13% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 57.14% | 72.89% | 15.92% | -89.44% |
| Revenue | N/A | N/A | N/A | N/A |